每周一次的老年乳腺癌Hypofractionated 放疗同步整合增敏：初步证据。
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence.
机构信息
Department of Radiation Oncology, IRCCS Policlinico San Martino, Genoa, Italy
Department of Radiation Oncology, IRCCS Policlinico San Martino, Genoa, Italy.
出版信息
In Vivo. 2019 Nov-Dec;33(6):1985-1992. doi: 10.21873/invivo.11694.
Abstract
AIM
To evaluate once-weekly hypofractionated radiotherapy in elderly patients affected by early breast cancer, reporting acute and late toxicity profiles, and treatment feasibility.
PATIENTS AND METHODS
Fifty patients were treated with a hypofractionated regimen: 28.5±2.5 Gy in five fractions at one fraction weekly. Simultaneous integrated boost (SIB) to the tumor bed in high-risk cases.
INCLUSION CRITERIA
patients over 70 years old, pT1-2, N0-1a. Acute and late toxicities were assessed based on Radiation Therapy Oncology Group.
RESULTS
The median follow-up was 20 months and the median patient age was 79 years. SIB was added for 22 patients (44%). Grade 3-4 acute cutaneous toxicities were not observed; grade 2 toxicity occurred only in four patients (8%). Late subcutaneous tissue toxicity consisted of grade 2 fibrosis in two patients (4%), grade 1 in five (10%) and grade 0 in 41(85%).
CONCLUSION
Limiting fraction numbers with a safer profile may improve the management of breast cancer for the elderly.
摘要
目的
评估每周一次的超分割放疗在老年早期乳腺癌患者中的应用，报告急性和晚期毒性概况以及治疗可行性。
患者和方法
50 例患者接受超分割方案治疗：28.5±2.5Gy，每周一次，共 5 次。高危病例采用肿瘤床同步整合 boost（SIB）。
纳入标准
年龄>70 岁，pT1-2，N0-1a。根据放射治疗肿瘤学组评估急性和晚期毒性。
结果
中位随访时间为 20 个月，中位患者年龄为 79 岁。22 例（44%）患者加用 SIB。未观察到 3-4 级急性皮肤毒性；仅 4 例（8%）患者出现 2 级毒性。晚期皮下组织毒性包括 2 例（4%）2 级纤维化，5 例（10%）1 级和 41 例（85%）0 级。
结论
限制分次次数可改善老年乳腺癌的管理，且安全性更佳。
相似文献
1
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence.每周一次的老年乳腺癌Hypofractionated 放疗同步整合增敏：初步证据。
In Vivo. 2019 Nov-Dec;33(6):1985-1992. doi: 10.21873/invivo.11694.
2
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.采用容积调强弧形治疗技术进行乳腺癌辅助放疗的Hypofractionated 同期整合推量的 I- II 期研究：50 例治疗的可行性和早期毒性结果报告。
Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145.
3
Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.早期乳腺癌患者辅助放疗中的每周同步增敏：可行性初步结果
Tumori. 2008 Sep-Oct;94(5):706-11. doi: 10.1177/030089160809400511.
4
An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.保乳手术后每日同步加量的加速超分割放疗方案：可行性与毒性
J Egypt Natl Canc Inst. 2016 Mar;28(1):39-44. doi: 10.1016/j.jnci.2016.01.002. Epub 2016 Jan 28.
5
Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.早期乳腺癌瘤床推量加部分乳腺低分割照射的疗效分析。
Clin Breast Cancer. 2017 Dec;17(8):638-643. doi: 10.1016/j.clbc.2017.05.010. Epub 2017 May 25.
6
Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.保乳术后早期乳腺癌的适形调强同步推量放疗与常规分割放疗的临床观察与分析。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211064719. doi: 10.1177/15330338211064719.
7
Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.采用同步整合加量技术的辅助性乳腺癌放疗：临床与剂量学视角
J Med Imaging Radiat Oncol. 2013 Apr;57(2):222-9. doi: 10.1111/j.1754-9485.2012.02473.x. Epub 2013 Mar 26.
8
Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.大分割乳腺放疗：疗程更短，毒性更低。
Clin Breast Cancer. 2016 Aug;16(4):262-8. doi: 10.1016/j.clbc.2015.09.012. Epub 2015 Sep 25.
9
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.乳腺癌患者接受辅助化疗时的部分乳房加速放疗同步加量：一项病例系列前瞻性评估及文献复习。
Breast. 2018 Dec;42:31-37. doi: 10.1016/j.breast.2018.08.098. Epub 2018 Aug 22.
10
Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.保乳术后加速缩野适形放疗联合同期光子推量治疗早期乳腺癌的前瞻性研究：463 例患者的结果分析
Breast J. 2011 Nov-Dec;17(6):586-93. doi: 10.1111/j.1524-4741.2011.01159.x. Epub 2011 Sep 21.
引用本文的文献
1
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data.辅助治疗在老年乳腺癌患者中的疗效和安全性：真实世界数据的系统评价和荟萃分析。
Breast Cancer. 2024 Sep;31(5):739-753. doi: 10.1007/s12282-024-01622-1. Epub 2024 Aug 1.
2
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique.在真实环境下进行超分割全乳辅助放疗：271 例老年/虚弱患者采用 3D 和调强放疗技术治疗的单中心经验。
J Cancer Res Clin Oncol. 2022 Apr;148(4):823-835. doi: 10.1007/s00432-021-03907-w. Epub 2022 Jan 6.
3
Ten Daily Fractions for Whole Breast Cancer Irradiation: Long Term Results.每日 10 次分割全乳照射：长期结果。
In Vivo. 2021 Sep-Oct;35(5):2875-2880. doi: 10.21873/invivo.12576.
4
Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.年龄因素重要吗？保乳手术后局部区域复发风险的评估。
In Vivo. 2020 May-Jun;34(3):1125-1132. doi: 10.21873/invivo.11884.
本文引用的文献
1
[Hypofractionated radiotherapy for breast cancer in elderly patients: current evidence and future perspectives].老年乳腺癌患者的大分割放疗：当前证据与未来展望
Cancer Radiother. 2018 Oct;22(6-7):635-639. doi: 10.1016/j.canrad.2018.07.127. Epub 2018 Aug 22.
2
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.全乳放射治疗：美国放射肿瘤学会（ASTRO）基于证据的指南执行摘要。
Pract Radiat Oncol. 2018 May-Jun;8(3):145-152. doi: 10.1016/j.prro.2018.01.012. Epub 2018 Mar 12.
3
Breast cancer data analysis for survivability studies and prediction.乳腺癌数据分析用于生存研究和预测。
Comput Methods Programs Biomed. 2018 Mar;155:199-208. doi: 10.1016/j.cmpb.2017.12.011. Epub 2017 Dec 12.
4
Radiation Therapy in Elderly Persons: An Old Issue With New Approaches.老年人的放射治疗：一个有新方法的老问题。
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):715-717. doi: 10.1016/j.ijrobp.2016.11.032.
5
First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.早期乳腺癌每周一次大分割乳房照射（WHBI）2期试验的初步结果。
Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):595-602. doi: 10.1016/j.ijrobp.2017.01.212.
6
Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.局部区域淋巴结低分割照射治疗淋巴结阳性乳腺癌女性患者。
Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):563-570. doi: 10.1016/j.ijrobp.2016.11.010. Epub 2016 Nov 15.
7
External radiotherapy for breast cancer in the elderly.
Aging Clin Exp Res. 2017 Feb;29(Suppl 1):149-157. doi: 10.1007/s40520-016-0655-x. Epub 2016 Nov 11.
8
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.与英国FAST-Forward试验中采用的标准3周方案相比，全乳放疗1周方案相关的急性皮肤毒性。
Radiother Oncol. 2016 Jul;120(1):114-8. doi: 10.1016/j.radonc.2016.02.027. Epub 2016 Apr 1.
9
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.老年患者保乳手术后每周一次的大分割全乳放疗：一种可替代每日一次三周大分割放疗的潜在治疗方案。
Clin Breast Cancer. 2015 Aug;15(4):270-6. doi: 10.1016/j.clbc.2014.12.011. Epub 2015 Jan 7.
10
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.65 岁或以上早期乳腺癌女性中保乳手术联合或不联合放疗（PRIME II）：一项随机对照试验。
Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28.
Zotero 插件